Brightstone Venture Capital

The global computational biology market size is expected to reach USD 13.6 billion by 2024 | PR Newswire | 10/28/2019

… from angel investors. For instance, in February 2019 , StemoniX Inc., the U.S. based provider of product and services for drug discovery and development, received funding of USD 14.40 million from a group of investors. Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD …

David Dalvey - Twin Cities Business | 10/1/2019

… the company in 2012 and has served as its CEO and chairman since the company’s inception. But behind the scenes, David Dalvey is a key player. Dalvey is managing general partner with Minneapolis–based Brightstone Venture Capital , which invests in early-stage technology and life science companies in a range of industries. When Brightstone invested in Celcuity in 2014, Dalvey joined the board of directors. “I think he has an …

Follow Brightstone Venture Capital:    

Why Entrepreneurs Seeking Venture Capital Need Compelling Stories | 6/13/2019

11 Views “Who cares?” It’s the first question to ask when building a story for any entrepreneur who intends to approach institutional investors, says David Dalvey , founder of Brightstone Venture Capital in Minneapolis. With more than 25 years of experience reviewing and investing in early-stage business opportunities, Dalvey usually knows within minutes whether to continue talking with the founder of a new company. His first and most important screen …

NIH taps StemoniX’s organ-on-a-chip for opioid, addiction research | FierceBiotech | 5/1/2019

… microBrain, StemoniX offers microHeart—spontaneously beating heart cells on a plate—for screening drugs and modeling heart disease. The Minnesota-based company raised a $14.4 million B round in February from Alumni Ventures Group, Brightstone Venture Capital , Crescent Ridge Partners, Keshif Ventures, the Mayo Clinic and SEED San Diego. StemoniX earmarked the funds to expand its commercial operations at sites in Minnesota and California as well as to support the …

Global Computational Biology Market 2019-2026: Analysis on Cellular & Biological Simulation, Drug Discovery and Disease Modelling - ResearchAndMarkets.com | Business Wire | 4/10/2019

… from angel investors. For instance, in February 2019, StemoniX Inc., the U.S. based provider of product and services for drug discovery and development, received funding of USD 14.40 million from a group of investors. Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD …

StemoniX

The global computational biology market size is expected to reach USD 13.6 billion by 2024 | PR Newswire | 10/28/2019

StemoniX Inc., the U.S. based provider of product and services for drug discovery and development, received funding of USD 14.40 million from a group of investors. Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD 5.0 million to speed up the discovery of …

NIH taps StemoniX’s organ-on-a-chip for opioid, addiction research | FierceBiotech | 5/1/2019

The NIH’s National Center for Advancing Translational Sciences is teaming up with StemoniX to use its brain-on-a-chip platform to test new treatments for pain, opioid misuse and addiction. Under an addiction-focused … 14.4 million B round in February from Alumni Ventures Group, Brightstone Venture Capital, Crescent Ridge Partners, Keshif Ventures, the Mayo Clinic and SEED San Diego. StemoniX earmarked the funds to expand its commercial operations at …

Mayo Clinic

The global computational biology market size is expected to reach USD 13.6 billion by 2024 | PR Newswire | 10/28/2019

Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD 5.0 million to speed up the discovery of new drugs. With this finding, the research institute is planning to procure and install drug discovery research instruments and other drug discovery platforms. Further key findings …

NIH taps StemoniX’s organ-on-a-chip for opioid, addiction research | FierceBiotech | 5/1/2019

… Brightstone Venture Capital, Crescent Ridge Partners, Keshif Ventures, the Mayo Clinic and SEED San Diego. StemoniX earmarked the funds to expand its commercial operations at sites in Minnesota and California as well as to support the development of new products and services …